Legislative Progress
Introduced
March 31, 2020
Latest Action
March 31, 2020
Primary Sponsor
Janice D. SchakowskyDemocratic(IL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Protecting Cures Act of 2020 This bill prohibits the Department of Health and Human Services from withholding funding, because of ethical considerations, for research activities that use human fetal tissue, provided that the research activities have been recommended for approval by an institutional review board and otherwise comply with existing laws concerning human fetal tissue. The bill also establishes that this research is not unethical by deeming the 1988 report of the Human Fetal Tissue Transplantation Research Panel as meeting relevant statutory requirements with respect to approving the ethical status of such research.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2020 · fourth_quarter · Medical/Disease Research/Clinical Labs
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
P.L. 114-255, 21st Century Cures Act, Division A Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators. H.R. 6417, Protecting Cures Act of 2020 Issue: Support legislation to reiterate HHSs obligation to fund scientifically meritorious research that meets specified criteria. S. 3161, National Biomedical Research Act Issue: Support legislation to establish a Biomedical Innovation Fund. H.Res. 1125, Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19. Issue: Support clinical trials diversity. Issue: Support ethical use of fetal tissue in medical research.
Client expense: $1,035,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Science/Technology
Issues related to artificial intelligence research and development. H.R. 3038: Securing American Science and Technology Act of 2019. H.R. 3439: TO amend the Internal Revenue Code of 1986 and Title XI of the Social Security Act to extend appropriations and transfers to the Patient-Centered Outcomes Research Trust Fund and to extend certain health insurance fees for such transfers, and for other purposes (PATIENT ACT), entire bill. Issues related to foreign influence in research. H.R. 6417: Protecting Cures Act of 2020, entire bill. H.R. 7308: The Research Investment to Spark the Economy"(RISE) Act H.R. 6978: Endless Frontier Act
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
H.R. 985, Fair Access for Safe and Timely Generics Act of 2019 (FAST Generics Act), support passage. H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage H.R. 2781 - Empower for Health Act of 2019, support passage H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage H.R. 3630 - No Surprises Act, support passage H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. H.R 3 - Lower Drug Costs Now Act of 2019, support passage H.R. 19 - Lower Costs, More Cures Act of 2019, support passage H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage H.R. 6417, Protecting Cures Act of 2020, support passage H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage S. 1935, Family Coverage Act, support passage. S.1556, No Junk Plans Act, support passage. S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage S. 659, Biologic Patent Transparency Act, support passage S.1895 - Lower Health Care Costs Act, support passage S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage S. 1801, Low Cost Generics Act of 2019, support passage H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support H.R. 6514, Worker Health Coverage Protection Act, Support H.R. 3832, S. 1257, Legacy IRA Act, Support H.R. 6408 - Save the Organizations that Serve America Act S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support S. 3815, RESTART Act, Oppose S. 3833/H.R. 7010/H.R.6886, Paycheck Protection Program Flexibility Act of 2020, Support S. 4032/H.R. 7324, Universal Giving Pandemic Response Act. Support passage H.R. 6892-Help Charities Protect Communities Act, Support - S.Amdt. 1566 to the CARES Act, Charitable Giving oAmendment Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support. H.R. 7663-Protecting Access to Post-COVID-19 Telehealth Act, support passage H.R. 6644/S. 3741 - Health Care At Home Act, support passage H.R. 7391- the Protect Telehealth Access Act, support passage S. 3998- the Enhancing Preparedness Through Telehealth Act, support passage
Client expense: $48,803 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2020 · fourth_quarter · Medical/Disease Research/Clinical Labs
Sickle cell disease/trait issues Hematology/oncology treatment issues General hematology public health and research issues Fetal tissue research Protecting Cures Act of 2020 (H.R. 6417) Open access policy for peer reviewed research journals Issues impacting blood safety/shortages Issues related to convalescent plasma Issues impacting delivery of bone marrow, peripheral blood, and cord blood Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748/P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations
Client expense: $30,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
2020 · third_quarter · Medical/Disease Research/Clinical Labs
P.L. 114-255, 21st Century Cures Act, Division A Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators. H.R. 6417, Protecting Cures Act of 2020 Issue: Support legislation to reiterate HHSs obligation to fund scientifically meritorious research that meets specified criteria. S. 3161, National Biomedical Research Act Issue: Support legislation to establish a Biomedical Innovation Fund. H.Res. 1125, Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19. Issue: Support clinical trials diversity. Issue: Support ethical use of fetal tissue in medical research.
Client expense: $1,095,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · third_quarter · Medical/Disease Research/Clinical Labs
Sickle cell disease/trait issues Hematology/oncology treatment issues General hematology public health and research issues Fetal tissue research Protecting Cures Act of 2020 (H.R. 6417) Open access policy for peer reviewed research journals Issues impacting blood safety/shortages Issues related to convalescent plasma Issues impacting delivery of bone marrow, peripheral blood, and cord blood Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748/P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations
Client expense: $30,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
2020 · third_quarter · Science/Technology
Issues related to artificial intelligence research and development. H.R. 3038: Securing American Science and Technology Act of 2019. H.R. 3439: TO amend the Internal Revenue Code of 1986 and Title XI of the Social Security Act to extend appropriations and transfers to the Patient-Centered Outcomes Research Trust Fund and to extend certain health insurance fees for such transfers, and for other purposes (PATIENT ACT), entire bill. Issues related to foreign influence in research. H.R. 6417: Protecting Cures Act of 2020, entire bill. H.R. 7308: The Research Investment to Spark the Economy"(RISE) Act H.R. 6978: Endless Frontier Act
Client expense: $98,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
H.R. 985, Fair Access for Safe and Timely Generics Act of 2019 (FAST Generics Act), support passage. H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage H.R. 2781 - Empower for Health Act of 2019, support passage H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage H.R. 3630 - No Surprises Act, support passage H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. H.R 3 - Lower Drug Costs Now Act of 2019, support passage H.R. 19 - Lower Costs, More Cures Act of 2019, support passage H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage H.R. 6417, Protecting Cures Act of 2020, support passage H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage S. 1935, Family Coverage Act, support passage. S.1556, No Junk Plans Act, support passage. S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage S. 659, Biologic Patent Transparency Act, support passage S.1895 - Lower Health Care Costs Act, support passage S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage S. 1801, Low Cost Generics Act of 2019, support passage H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support H.R. 6514, Worker Health Coverage Protection Act, Support H.R. 3832, S. 1257, Legacy IRA Act, Support H.R. 6408 - Save the Organizations that Serve America Act S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support S. 3815, RESTART Act, Oppose S. 3833/H.R. 7010/H.R.6886, Paycheck Protection Program Flexibility Act of 2020, Support S. 4032/H.R. 7324, Universal Giving Pandemic Response Act. Support passage H.R. 6892-Help Charities Protect Communities Act, Support - S.Amdt. 1566 to the CARES Act, Charitable Giving oAmendment Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support. H.R. 7663-Protecting Access to Post-COVID-19 Telehealth Act, support passage H.R. 6644/S. 3741 - Health Care At Home Act, support passage H.R. 7391- the Protect Telehealth Access Act, support passage S. 3998- the Enhancing Preparedness Through Telehealth Act, support passage
2020 · second_quarter · Health Issues
- H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -H.R. 19 - Lower Costs, More Cures Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage - H.R. 6417, Protecting Cures Act of 2020, support passage - H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption S, 1801, Low Cost Generics Act of 2019, support passage S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage. - H.R. 1425 Patient Protection and Affordable Care Enhancement Act, support - H.R. 6514, Worker Health Coverage Protection Act, Support - H.R. 3832, S. 1257, Legacy IRA Act, Support - H.R. 6408 - Save the Organizations that Serve America Act - S.3544/H.R.6305 - Coronavirus Relief for Seniors and People with Disabilities Act of 2020, support -RESTART Act (S. 3814), Oppose - Paycheck Protection Program Flexibility Act of 2020(S. 3833/H.R. 7010/H.R.6886) Support -Help Charities Protect Communities Act (Rep. Beatty), bill number to be determined. Support - S.Amdt. 1566 to the CARES Act,Charitable Giving Amendment.Increases the $300 limit on the charitable giving deduction to one-third of the standard deduction ($4,000 for an individual filer/$8,000 for married joint filers) for the remainder of 2020. Support.
2020 · second_quarter · Medical/Disease Research/Clinical Labs
P.L. 114-255, 21st Century Cures Act, Division A Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators. H.R. 6417, Protecting Cures Act of 2020 Issue: Support legislation to reiterate HHSs obligation to fund scientifically meritorious research that meets specified criteria. S. 3161, National Biomedical Research Act Issue: Support legislation to establish a Biomedical Innovation Fund.
Client expense: $1,316,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · second_quarter · Medical/Disease Research/Clinical Labs
Sickle cell disease/trait issues Hematology/oncology treatment issues General hematology public health and research issues Fetal tissue research Protecting Cures Act of 2020 (H.R. 6417) Open access policy for peer reviewed research journals Issues impacting blood safety/shortages Issues related to convalescent plasma Issues impacting delivery of bone marrow, peripheral blood, and cord blood Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748/P.L. 116-136) H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Issues related to health equity/disproportionate impact of COVID-19 on minority populations
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2020 · second_quarter · Science/Technology
Issues related to artificial intelligence research and development. H.R. 3038: Securing American Science and Technology Act of 2019. H.R. 3439: TO amend the Internal Revenue Code of 1986 and Title XI of the Social Security Act to extend appropriations and transfers to the Patient-Centered Outcomes Research Trust Fund and to extend certain health insurance fees for such transfers, and for other purposes (PATIENT ACT), entire bill. Issues related to foreign influence in research. H.R. 6417: Protecting Cures Act of 2020, entire bill. H.R. 7308: The Research Investment to Spark the Economy"(RISE) Act
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Medical/Disease Research/Clinical Labs
P.L. 114-255, 21st Century Cures Act, Division A Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators. H.R. 6417, Protecting Cures Act of 2020 Issue: Support legislation to reiterate HHSs obligation to fund scientifically meritorious research that meets specified criteria. S. 3161, National Biomedical Research Act Issue: Support legislation to establish a Biomedical Innovation Fund.
Client expense: $982,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · first_quarter · Medical/Disease Research/Clinical Labs
Sickle cell disease/trait issues Hematology/oncology treatment issues General hematology public health and research issues Fetal tissue research Protecting Cures Act of 2020 (H.R. 6417) Open access policy for peer reviewed research journals Response to Request for Public Comment on Draft Desirable Characteristics of Repositories for Managing and Sharing Data Resulting from Federally Funded Research [FR Doc. 2020-00689] Response to NIH Request for Public Comments on a DRAFT NIH Policy for Data Management and Sharing and Supplemental DRAFT Guidance [NOT-OD-20-013] Response to National Library of Medicine RFI on Modernization of ClinicalTrials.gov (NOT-LM-20-003) Issues impacting blood safety/shortages/deferral policy Issues related to convalescent plasma
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
2020 · first_quarter · Health Issues
Newborn Screening Saves Lives Reauthorization, Reforms to the Military Health System / TRICARE Exceptional Family Member Program, Stopping Military Medical Personnel Billet Reductions, VACCINES Act - Inclusion in Coronavirus (COVID-19) Legislative Vehicles, FY21 Labor, Health and Human Services, and Education Appropriations: CDC/NIH Firearm Injury and Mortality Prevention Research, HRSA Emergency Medical Services for Children, HRSA Pediatric Subspecialty Loan Repayment Program, CDC National Center for Birth Defects and Developmental Disabilities, ACF Child Abuse Prevention and Treatment Act Grants, CDC Global Immunization Programs, ASPR Pediatric Disaster Care Pilot Program, HRSA Pediatric Mental Health Care Access, HRSA Screening and Treatment for Maternal Depression, NIH Adolescent E-Cigarette Cessation Research, SAMHSA Reducing Underage Drinking Through Screening, Brief Intervention, and Referral to Treatment, FY21 Agriculture, Rural Development, and FDA Appropriations: USDA/FNS WIC Breastfeeding Peer Counselor Program and FDA Pediatric Device Consortia, Healthy Start Reauthorization, Families First Coronavirus Response Act (HR 6201), Coronavirus Aid, Relief, and Economic Security Act (S 3548), Child Abuse Prevention and Treatment Act reauthorization, CAPTA Plans of safe care grants, Family First Prevention Services Act implementation, Maternal, Infant, and Early Childhood Home Visiting Program funding, Gun violence prevention research funding, Sudden Unexpected Infant Death (HR 2271 / S 1130), STURDY Act (HR 2211 / S 1902), Safe Sleep for Babies Act (HR 3172 / S 1767), Child product safety, Issues related to the COVID-19 pandemic and providing supports for the child welfare community, Funding for Child Care and Development Black Grant, Providing Americans Insured Days of Leave Act, Infant sleep product safety, Magnet Injury Prevention, Lead exposure, Regulation of air pollutants, Paid Family Leave, Climate change, TSCA Implementation, IHS Funding, Indian Health Service Health Professions Tax Fairness Act (HR 6448 / S 2871), REMOTE Act, Standards in CBP Custody, S. 2135, Standards in ICE Family Detention, Standards in ORR Custody, Public Charge, Child Nutrition Reauthorization/WIC, SNAP, Mental Health for Children, OTC Drug Reform, Requirements for airplane EMKs, H.R. 6, DREAM Act, Family Separation and Detention, Fair Day in Court for Kids Act, Menu Labeling, Nutrition Facts Label, Equality Act, HR 5, CARE for Families Act HR 3107, WIC Act, Keep Families Together Act, Breastfeeding Peer Counseling Program, Public Health Preparedness and Response, Medical Nutrition Equity Act, Therapeutic Fraud Prevention Act, Funding for Mental Health Access Grants, Funding for HRSA Maternal Depression Grants, Research for Pregnant and Lactating Women, Palliative Care and Hospice Education and Training Act (S. 2080), Medical Deferred Action, Access to Healthy Food for Young Children Act of 2019 (S. 2501), H.R. 3246, Traveling Parents Screening Consistency Act of 2019, Friendly Airports for Mothers Expansion (FAME) Act, Healthy Meals for Opioid-Affected Kids and Kids Raised by Grandfamilies , 21st Century Cures 2.0, Dietary Guidelines, Families First Coronavirus Response Act, Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pediatric Disaster Care Pilot Program, Child Poverty, Funding for the Emergency Medical Services for Children (EMSC) Program, Funding for Pediatric Device Consortia, PUMP for Nursing Mothers Act, S. 3170, 12-Month Continuous Medicaid/CHIP Eligibility, Medicaid Work Requirements, Medicaid Eligibility Proposed Rule, Medicaid Block Grants, Medicaid Per Capita Caps, Section 1115 Medicaid Waivers, Increase to Medicaid FMAP During COVID-19, Establish an automatic FMAP increase tied to state economic indicators, HR 6159, the Kids Access to Primary Care Act, Medicaid Maintenance of Effort (MOE) Protections, Comprehensive Access to Robust Insurance Now Guaranteed (CARING) for Kids Act (H.R.6151), H.R.6098 to Expand State CHIP Eligibility, Delaying the CHIP FMAP Decrease, Medicaid Fiscal Accountability Rule, Maternal Health, Expanding Medicaid to 12 Months Post-Partum, Medicaid Premiums and Cost Sharing, Medicaid Payment for Eligibility Workers. Recoupment of the Payment Error Rate Measurement (PERM), Expanding the use of Telehealth in Medicaid/CHIP/Private Insurance, Allow for the home and other secure locations as originating (patient) and distant (provider) sites in telehealth, Waive telehealth cost-sharing for patients in telehealth, Pay for telehealth care visits at parity with that of in-person visits, Allow telehealth care for both new and established patients, Expanding Capacity for Health Outcomes (ECHO) Act of 2019 (S 1618/HR 5199), Including Preventive Medicine Service Codes to be Eligible for Telehealth, Public Health and Social Services Emergency Funding, Financial Relief to Medicaid Providers, COVID-19 Response, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), Families First Coronavirus Response Act (H.R. 6201), Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748)Proposed Repeal of Medicaid Access Rule , Medicaid Payment Parity, Reversing the Youth Tobacco Epidemic Act (H.R. 2339), EMPOWER for Health Act (H.R. 2781), Investment in Tomorrow's Pediatric Health Care Workforce Act (S. 2443), Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997), National Institutes of Health Appropriations, Title VII Health Professions Programs Appropriations, NIH Environmental influences on Child Health Outcomes Appropriations, Pediatric Subspecialty Loan Repayment Program Appropriations, Food Allergy Appropriations Initiatives, CARES Act, Protecting Cures Act of 2020 (H.R. 6417), Fetal Tissue Research
2020 · first_quarter · Science/Technology
Issues related to artificial intelligence research and development. H.R. 3038: Securing American Science and Technology Act of 2019. H.R. 3439: TO amend the Internal Revenue Code of 1986 and Title XI of the Social Security Act to extend appropriations and transfers to the Patient-Centered Outcomes Research Trust Fund and to extend certain health insurance fees for such transfers, and for other purposes (PATIENT ACT), entire bill. Issues related to foreign influence in research. H.R. 6417: Protecting Cures Act of 2020, entire bill.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
- H.R. 985, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage. -H.R. 2035/S. 995, Lifespan Respite Care Reauthorization Act, support reauthorization - H.R. 3208/ S.1755 - Real Emergency Access for Aging and Disability Inclusion for Disasters Act, support passage - H.R. 3215/ S. 1754 - Disaster Relief Medicaid Act, support passage - S.2400/ H.R. 4322 - Expanding Cannabis Research and Information Act, support passage - H.R. 3439 - Reauthorization of the Patient Centered Outcomes Research Institute, support reauthorization. -H.R. 2781 - Empower for Health Act of 2019, support passage -H.R. 2296/S.1391 - FAIR Drug Pricing Act of 2019, support passage - H.R. 3630 - No Surprises Act, support passage -H.R. 1010, To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect, support passage. -H.R. 986, The Protecting Americans with Preexisting Conditions Act of 2019, support passage. -H.R.1386, Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019, support passage. -H.R. 2293, the Protecting Access to Wheelchairs Act, support passage. -H.R. 2408, the Ensuring Access to Quality Complex Rehabilitation technology Act, support passage. -H.R 3 - Lower Drug Costs Now Act of 2019, support passage -H.R. 19 - Lower Costs, More Cures Act of 2019, support passage - H.R. 2387, the Stop The Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act of 2019, support passage - H.R. 3107, Improving Seniors Timely Access to Care Act of 2019, support passage - H.R. 6417, Protecting Cures Act of 2020, support passage - H.R. 5800, Ban Surprise Billing Act, support passage H.R. 1595, Secure and Fair Enforcement Banking Act (SAFE Banking Act), support passage -S. 1935, Family Coverage Act, support passage. -S.1556, No Junk Plans Act, support passage. -S. 1223, the Protecting Beneficiary Access to Complex Rehab Technology Act, support passage - S.475, Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2019 (RX Cap Act), support passage - S. 637, Combatting Unreasonable Rises and Excessively High Drug Prices Act (CURE High Drug Prices Act), support passage - S.366, Forcing Limits on Abusive and Tumultuous Prices (FLAT Prices) Act, support passage -S. 63, Preserve Access to Affordable Generics and Biosimilars Act, support passage -S. 659, Biologic Patent Transparency Act, support passage -S.1895 - Lower Health Care Costs Act, support passage - S. 1280/HR 2477 - Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act, support passage - S. 691 - Medicare Extra Rx Help Act- support passage - S. 2543 - Prescription Drug Price Reduction Act of 2019 - support passage - Menendez - Lankford- Cardin-Daines Amendment 1 Incentivizing Generic and Biosimilar Use in Medicare Part D - support adoption Menendez -Lankford - Cardin --Daines Amendment 2 Incentivizing Generic Use in Medicare Part D - support adoption S, 1801, Low Cost Generics Act of 2019, support passage S.2911, the Seniors Prescription Drug Relief Act of 2019, support passage.
| Democratic |
| NJ |
| David J. Trone | Democratic | MD |
| David N. Cicilline | Democratic | RI |
| Debra A. Haaland | Democratic | NM |
| Diana DeGette | Democratic | CO |
| Eleanor Holmes Norton | Democratic | DC |
| Jackie Speier | Democratic | CA |
| Jahana Hayes | Democratic | CT |
| James P. McGovern | Democratic | MA |
| Jamie Raskin | Democratic | MD |
| Jared Huffman | Democratic | CA |
| Jerrold Nadler | Democratic | NY |
| Judy Chu | Democratic | CA |
| Lois Frankel | Democratic | FL |
| Mark Pocan | Democratic | WI |
| Peter Welch | Democratic | VT |
| Sheila Jackson Lee | Democratic | TX |
| Steve Cohen | Democratic | TN |
| Suzan K. DelBene | Democratic | WA |
Client expense: $57,579 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Client expense: $85,876 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $280,000 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE)
Client expense: $132,919 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE